Hindustan Unilever Limited has informed the Exchange regarding Board meeting held on February 12, 2026.

EBITDA margin compressionExceptional itemResults View source PDF Explain this filing

HINDUNILVR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.1%Reaction day

₹2457.70

prior close

₹2448.80

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.5%-1.5% vs market

Fast Moving Consumer Goods peers, median of 285sector · sector level-0.7%-1.4% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty 100 and 1.4 pts less than its Fast Moving Consumer Goods peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-1.1

15m

-1.3

30m

-1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.1-0.5-1.5-0.7-1.4

Next day

-6.2-1.9-4.3-1.7-4.5

-5.7-1.0-4.6-2.2-3.5

-5.9-0.8-5.1-1.9-4.0

-5.4-0.4-5.0-1.8-3.6

-7.1-1.9-5.3-2.4-4.8

-4.4-0.9-3.5-2.4-2.1

15d

-9.5-5.5-4.1-6.6-3.0

-13.2-8.3-4.8-7.8-5.4

-13.7-7.5-6.2-4.2-9.5

-7.8-8.6+0.8-1.5-6.3

UpDownMarket · Nifty 100Sector · Fast Moving Consumer Goods peers, median of 285Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

HUL's Board approved its Q3 FY26 (quarter ended 31 Dec 2025) results. Consolidated sales from continuing operations rose 6% to Rs. 16,235 crores, while EBITDA grew 3% to Rs. 3,788 crores with margin compressing 70 bps to 23.3%. Profit after tax from continuing operations fell 30% YoY to Rs. 2,118 crores, but reported PAT jumped 121% to Rs. 6,603 crores, driven by a one-time exceptional gain of Rs. 4,611 crores from the demerger of its ice cream business into Kwality Wall's (India) Limited, effective 1 Dec 2025. Standalone sales grew 4% to Rs. 15,614 crores, with EBITDA margin down 50 bps to 23.3%. The Board also approved acquiring the remaining 49% stake in Zywie Ventures and divesting its stake in Nutritionalab. Statutory auditors Walker Chandiok & Co LLP issued an unmodified review report.

Likely market impact

Underlying business momentum is modest with single-digit sales growth and margin compression, but reported earnings are flattered by a large non-recurring demerger gain. Investors should focus on continuing-operations PAT (down 30%) and shrinking EBITDA margins as a more accurate read on core performance, while the demerger sharpens HUL's portfolio focus on higher-growth segments.